Advertisement

Topics

Amplyx Raises $67m For Antifungals Against Life-Threatening Pathogens

22:09 EDT 1 Aug 2017 | SCRIP

Investors were impressed by the company's broad-spectrum, IV and oral antifungal drug in a space where few treatment options exist;...

      

Related Stories

 

Original Article: Amplyx Raises $67m For Antifungals Against Life-Threatening Pathogens

NEXT ARTICLE

More From BioPortfolio on "Amplyx Raises $67m For Antifungals Against Life-Threatening Pathogens"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...